Recombinant Human Coagulation VIIa Market, Global Outlook and Forecast 2022-2028

August 2022 | 77 pages | ID: R9F8ACB8ED9AEN
Market Monitor Global

Abstracts

Recombinant activated factor VII (rFVIIa) binds to exposed tissue factor at the place of tissue and vascular injury. Thrombin generated by this process activates platelets and the coagulation cascade.

This report contains market size and forecasts of Recombinant Human Coagulation VIIa in global, including the following market information:

Global Recombinant Human Coagulation VIIa Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Recombinant Human Coagulation VIIa Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Recombinant Human Coagulation VIIa companies in 2021 (%)

The global Recombinant Human Coagulation VIIa market was valued at 1166.6 million in 2021 and is projected to reach US$ 1488.4 million by 2028, at a CAGR of 3.5% during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Prefilled Syringe Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant Human Coagulation VIIa include Novo Nordisk, LFB SA HEMA Biologics, AryoGen Pharmed and GENERIUM, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Human Coagulation VIIa manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Human Coagulation VIIa Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Recombinant Human Coagulation VIIa Market Segment Percentages, by Type, 2021 (%)

• Prefilled Syringe
• Vial

Global Recombinant Human Coagulation VIIa Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Recombinant Human Coagulation VIIa Market Segment Percentages, by Application, 2021 (%)

• Congenital Hemophilia
• Acquired Hemophilia
• Others

Global Recombinant Human Coagulation VIIa Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Recombinant Human Coagulation VIIa Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant Human Coagulation VIIa revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Recombinant Human Coagulation VIIa revenues share in global market, 2021 (%)

Key companies Recombinant Human Coagulation VIIa sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Recombinant Human Coagulation VIIa sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novo Nordisk
• LFB SA HEMA Biologics
• AryoGen Pharmed
• GENERIUM

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Recombinant Human Coagulation VIIa Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Recombinant Human Coagulation VIIa Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RECOMBINANT HUMAN COAGULATION VIIA OVERALL MARKET SIZE

2.1 Global Recombinant Human Coagulation VIIa Market Size: 2021 VS 2028
2.2 Global Recombinant Human Coagulation VIIa Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Human Coagulation VIIa Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Recombinant Human Coagulation VIIa Players in Global Market
3.2 Top Global Recombinant Human Coagulation VIIa Companies Ranked by Revenue
3.3 Global Recombinant Human Coagulation VIIa Revenue by Companies
3.4 Global Recombinant Human Coagulation VIIa Sales by Companies
3.5 Global Recombinant Human Coagulation VIIa Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Human Coagulation VIIa Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Human Coagulation VIIa Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Human Coagulation VIIa Players in Global Market
  3.8.1 List of Global Tier 1 Recombinant Human Coagulation VIIa Companies
  3.8.2 List of Global Tier 2 and Tier 3 Recombinant Human Coagulation VIIa Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Recombinant Human Coagulation VIIa Market Size Markets, 2021 & 2028
  4.1.2 Prefilled Syringe
  4.1.3 Vial
4.2 By Type - Global Recombinant Human Coagulation VIIa Revenue & Forecasts
  4.2.1 By Type - Global Recombinant Human Coagulation VIIa Revenue, 2017-2022
  4.2.2 By Type - Global Recombinant Human Coagulation VIIa Revenue, 2023-2028
  4.2.3 By Type - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Human Coagulation VIIa Sales & Forecasts
  4.3.1 By Type - Global Recombinant Human Coagulation VIIa Sales, 2017-2022
  4.3.2 By Type - Global Recombinant Human Coagulation VIIa Sales, 2023-2028
  4.3.3 By Type - Global Recombinant Human Coagulation VIIa Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Human Coagulation VIIa Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Recombinant Human Coagulation VIIa Market Size, 2021 & 2028
  5.1.2 Congenital Hemophilia
  5.1.3 Acquired Hemophilia
  5.1.4 Others
5.2 By Application - Global Recombinant Human Coagulation VIIa Revenue & Forecasts
  5.2.1 By Application - Global Recombinant Human Coagulation VIIa Revenue, 2017-2022
  5.2.2 By Application - Global Recombinant Human Coagulation VIIa Revenue, 2023-2028
  5.2.3 By Application - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Human Coagulation VIIa Sales & Forecasts
  5.3.1 By Application - Global Recombinant Human Coagulation VIIa Sales, 2017-2022
  5.3.2 By Application - Global Recombinant Human Coagulation VIIa Sales, 2023-2028
  5.3.3 By Application - Global Recombinant Human Coagulation VIIa Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Human Coagulation VIIa Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Recombinant Human Coagulation VIIa Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Human Coagulation VIIa Revenue & Forecasts
  6.2.1 By Region - Global Recombinant Human Coagulation VIIa Revenue, 2017-2022
  6.2.2 By Region - Global Recombinant Human Coagulation VIIa Revenue, 2023-2028
  6.2.3 By Region - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Human Coagulation VIIa Sales & Forecasts
  6.3.1 By Region - Global Recombinant Human Coagulation VIIa Sales, 2017-2022
  6.3.2 By Region - Global Recombinant Human Coagulation VIIa Sales, 2023-2028
  6.3.3 By Region - Global Recombinant Human Coagulation VIIa Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Recombinant Human Coagulation VIIa Revenue, 2017-2028
  6.4.2 By Country - North America Recombinant Human Coagulation VIIa Sales, 2017-2028
  6.4.3 US Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.4.4 Canada Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.4.5 Mexico Recombinant Human Coagulation VIIa Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Recombinant Human Coagulation VIIa Revenue, 2017-2028
  6.5.2 By Country - Europe Recombinant Human Coagulation VIIa Sales, 2017-2028
  6.5.3 Germany Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.5.4 France Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.5.5 U.K. Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.5.6 Italy Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.5.7 Russia Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.5.8 Nordic Countries Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.5.9 Benelux Recombinant Human Coagulation VIIa Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Recombinant Human Coagulation VIIa Revenue, 2017-2028
  6.6.2 By Region - Asia Recombinant Human Coagulation VIIa Sales, 2017-2028
  6.6.3 China Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.6.4 Japan Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.6.5 South Korea Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.6.6 Southeast Asia Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.6.7 India Recombinant Human Coagulation VIIa Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Recombinant Human Coagulation VIIa Revenue, 2017-2028
  6.7.2 By Country - South America Recombinant Human Coagulation VIIa Sales, 2017-2028
  6.7.3 Brazil Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.7.4 Argentina Recombinant Human Coagulation VIIa Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Recombinant Human Coagulation VIIa Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Recombinant Human Coagulation VIIa Sales, 2017-2028
  6.8.3 Turkey Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.8.4 Israel Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.8.5 Saudi Arabia Recombinant Human Coagulation VIIa Market Size, 2017-2028
  6.8.6 UAE Recombinant Human Coagulation VIIa Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Novo Nordisk
  7.1.1 Novo Nordisk Corporate Summary
  7.1.2 Novo Nordisk Business Overview
  7.1.3 Novo Nordisk Recombinant Human Coagulation VIIa Major Product Offerings
  7.1.4 Novo Nordisk Recombinant Human Coagulation VIIa Sales and Revenue in Global (2017-2022)
  7.1.5 Novo Nordisk Key News
7.2 LFB SA HEMA Biologics
  7.2.1 LFB SA HEMA Biologics Corporate Summary
  7.2.2 LFB SA HEMA Biologics Business Overview
  7.2.3 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Major Product Offerings
  7.2.4 LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Sales and Revenue in Global (2017-2022)
  7.2.5 LFB SA HEMA Biologics Key News
7.3 AryoGen Pharmed
  7.3.1 AryoGen Pharmed Corporate Summary
  7.3.2 AryoGen Pharmed Business Overview
  7.3.3 AryoGen Pharmed Recombinant Human Coagulation VIIa Major Product Offerings
  7.3.4 AryoGen Pharmed Recombinant Human Coagulation VIIa Sales and Revenue in Global (2017-2022)
  7.3.5 AryoGen Pharmed Key News
7.4 GENERIUM
  7.4.1 GENERIUM Corporate Summary
  7.4.2 GENERIUM Business Overview
  7.4.3 GENERIUM Recombinant Human Coagulation VIIa Major Product Offerings
  7.4.4 GENERIUM Recombinant Human Coagulation VIIa Sales and Revenue in Global (2017-2022)
  7.4.5 GENERIUM Key News

8 GLOBAL RECOMBINANT HUMAN COAGULATION VIIA PRODUCTION CAPACITY, ANALYSIS

8.1 Global Recombinant Human Coagulation VIIa Production Capacity, 2017-2028
8.2 Recombinant Human Coagulation VIIa Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Human Coagulation VIIa Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 RECOMBINANT HUMAN COAGULATION VIIA SUPPLY CHAIN ANALYSIS

10.1 Recombinant Human Coagulation VIIa Industry Value Chain
10.2 Recombinant Human Coagulation VIIa Upstream Market
10.3 Recombinant Human Coagulation VIIa Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Recombinant Human Coagulation VIIa Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Recombinant Human Coagulation VIIa in Global Market
Table 2. Top Recombinant Human Coagulation VIIa Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant Human Coagulation VIIa Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant Human Coagulation VIIa Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant Human Coagulation VIIa Sales by Companies, (K Units), 2017-2022
Table 6. Global Recombinant Human Coagulation VIIa Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant Human Coagulation VIIa Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Human Coagulation VIIa Product Type
Table 9. List of Global Tier 1 Recombinant Human Coagulation VIIa Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Human Coagulation VIIa Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Recombinant Human Coagulation VIIa Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Recombinant Human Coagulation VIIa Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Recombinant Human Coagulation VIIa Sales (K Units), 2017-2022
Table 15. By Type - Global Recombinant Human Coagulation VIIa Sales (K Units), 2023-2028
Table 16. By Application – Global Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant Human Coagulation VIIa Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant Human Coagulation VIIa Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant Human Coagulation VIIa Sales (K Units), 2017-2022
Table 20. By Application - Global Recombinant Human Coagulation VIIa Sales (K Units), 2023-2028
Table 21. By Region – Global Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant Human Coagulation VIIa Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant Human Coagulation VIIa Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant Human Coagulation VIIa Sales (K Units), 2017-2022
Table 25. By Region - Global Recombinant Human Coagulation VIIa Sales (K Units), 2023-2028
Table 26. By Country - North America Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant Human Coagulation VIIa Sales, (K Units), 2017-2022
Table 29. By Country - North America Recombinant Human Coagulation VIIa Sales, (K Units), 2023-2028
Table 30. By Country - Europe Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant Human Coagulation VIIa Sales, (K Units), 2017-2022
Table 33. By Country - Europe Recombinant Human Coagulation VIIa Sales, (K Units), 2023-2028
Table 34. By Region - Asia Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant Human Coagulation VIIa Sales, (K Units), 2017-2022
Table 37. By Region - Asia Recombinant Human Coagulation VIIa Sales, (K Units), 2023-2028
Table 38. By Country - South America Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant Human Coagulation VIIa Sales, (K Units), 2017-2022
Table 41. By Country - South America Recombinant Human Coagulation VIIa Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant Human Coagulation VIIa Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant Human Coagulation VIIa Sales, (K Units), 2023-2028
Table 46. Novo Nordisk Corporate Summary
Table 47. Novo Nordisk Recombinant Human Coagulation VIIa Product Offerings
Table 48. Novo Nordisk Recombinant Human Coagulation VIIa Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. LFB SA HEMA Biologics Corporate Summary
Table 50. LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Product Offerings
Table 51. LFB SA HEMA Biologics Recombinant Human Coagulation VIIa Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. AryoGen Pharmed Corporate Summary
Table 53. AryoGen Pharmed Recombinant Human Coagulation VIIa Product Offerings
Table 54. AryoGen Pharmed Recombinant Human Coagulation VIIa Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. GENERIUM Corporate Summary
Table 56. GENERIUM Recombinant Human Coagulation VIIa Product Offerings
Table 57. GENERIUM Recombinant Human Coagulation VIIa Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Recombinant Human Coagulation VIIa Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 59. Global Recombinant Human Coagulation VIIa Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Recombinant Human Coagulation VIIa Production by Region, 2017-2022 (K Units)
Table 61. Global Recombinant Human Coagulation VIIa Production by Region, 2023-2028 (K Units)
Table 62. Recombinant Human Coagulation VIIa Market Opportunities & Trends in Global Market
Table 63. Recombinant Human Coagulation VIIa Market Drivers in Global Market
Table 64. Recombinant Human Coagulation VIIa Market Restraints in Global Market
Table 65. Recombinant Human Coagulation VIIa Raw Materials
Table 66. Recombinant Human Coagulation VIIa Raw Materials Suppliers in Global Market
Table 67. Typical Recombinant Human Coagulation VIIa Downstream
Table 68. Recombinant Human Coagulation VIIa Downstream Clients in Global Market
Table 69. Recombinant Human Coagulation VIIa Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Human Coagulation VIIa Segment by Type
Figure 2. Recombinant Human Coagulation VIIa Segment by Application
Figure 3. Global Recombinant Human Coagulation VIIa Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant Human Coagulation VIIa Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Human Coagulation VIIa Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant Human Coagulation VIIa Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Human Coagulation VIIa Revenue in 2021
Figure 9. By Type - Global Recombinant Human Coagulation VIIa Sales Market Share, 2017-2028
Figure 10. By Type - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2017-2028
Figure 11. By Type - Global Recombinant Human Coagulation VIIa Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Recombinant Human Coagulation VIIa Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant Human Coagulation VIIa Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Recombinant Human Coagulation VIIa Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant Human Coagulation VIIa Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant Human Coagulation VIIa Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant Human Coagulation VIIa Sales Market Share, 2017-2028
Figure 19. US Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant Human Coagulation VIIa Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant Human Coagulation VIIa Sales Market Share, 2017-2028
Figure 24. Germany Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant Human Coagulation VIIa Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant Human Coagulation VIIa Sales Market Share, 2017-2028
Figure 33. China Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant Human Coagulation VIIa Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant Human Coagulation VIIa Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant Human Coagulation VIIa Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant Human Coagulation VIIa Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant Human Coagulation VIIa Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant Human Coagulation VIIa Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Recombinant Human Coagulation VIIa by Region, 2021 VS 2028
Figure 50. Recombinant Human Coagulation VIIa Industry Value Chain
Figure 51. Marketing Channels